Policy Research Grants
Funding For:
Quantifying Growth in Provider Billing Margins on Cancer Drugs
Health Care Costs & Quality
Recipient:
Aaron P Mitchell, Memorial Sloan Kettering Institute for Cancer Research
Grant Period:
Jan 01, 2026 - Dec 31, 2026
AMOUNT:
$49,967.00
Summary of the Project:
Oncology has the largest segment of clinician-administered drugs, and drug markups are a substantial revenue source for oncology practices. This study will quantify recent trends in provider revenue on cancer drug markups and the underlying factors driving these trends using manufacturer-reported drug revenue data and multi-payer claims (Medicare, Medicaid, and commercial).
Research Team:
Aaron P Mitchell, Memorial Sloan Kettering Cancer Center
Pragya Kakani, Cornell University
Aaron N Winn, University of Illinois Chicago